With 35 years of experience we are the preferred partner in brachytherapy and independent external beam treatment planning for more than 2,500 institutions worldwide. We continue to build on this with 500 dedicated employees, a global presence in more than 100 countries and an ongoing investment in innovation.
What matters to you, matters to us
We know that the clinical effectiveness of brachytherapy continues to make it a preferred treatment for radiotherapy centers across the world. This is precisely why we continue to invest in generating evidence and raising the awareness of brachytherapy.
Targeted solutions, Precise benefits
Through our connections with world leading clinical experts and our commitment to investing over 10% of our revenues into innovation we are able to continuously improve our solutions. Together, this makes brachytherapy both easy to deliver and a sound investment.
More than just technology
Our global network of over 45 application experts provides first class support, training and educational opportunities, whilst connecting you to leading radiotherapy centers and key opinion leaders. All this ensures you can deliver the best care in the world.
Brachytherapy is the placement of radioactive sources in or just next to a tumor. The word brachytherapy comes from
Nucletron is the leader in radiation oncology committed to developing solutions focused on improving patient care.
Nucletron employees live the company’s mission 24/7. A group of 550+ individuals who all bring their unique skills, experience...
Starting off a one-man company, Nucletron's goal was to develop a new cancer treatment method
Jos Lamers and Jan Sigger are Nucletron's Management Board. Meet them here.
Nucletron's offices can be found all around the world. Find your local office on this page
Nucletron All rights reserved